Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-01

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for dexmethylphenidate hydrochloride from Par Health USA, LLC. Dexmethylphenidate hydrochloride is used to treat att…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE (dexmethylphenidate hydrochloride)

Snippet

SUPPL AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)